MediLedger
MediLedger brings together expertise in both Pharmaceutical Supply Chain and Blockchain technologies.
- Company typePrivate
- Founded2017
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What MediLedger does
The MediLedger Project was launched by Chronicled in 2017. It brings together leading Pharmaceutical Manufacturers and Distributors using an advanced and customizable decentralized supply chain management system based on the principles of blockchain. This dynamic system innovates evolving solutions for track and trace regulations, and provides a step function improvement in the overall operation of the supply chain. The MediLedger Project is building an industry-owned permissioned blockchain network for the pharmaceutical sector based on open standards and specifications. Network nodes are set to be distributed among and operated by industry participants and technology providers who serve the industry. This decentralized network is only possible because the MediLedger Project has solved the sensitive issue of data privacy. No business intelligence is shared between partners, but rules are still enforceable due to zero-knowledge transaction verification across the supply chain. This approach can create a vibrant, open development environment and unlock innovative solutions for the pharmaceutical industry beyond the limits of what current technology can offer in the marketplace.
MediLedger firmographics
Firmographics- Name
- MediLedger
- Legal name
- Chronicled, Inc.
- Website
- https://www.mediledger.com/
- Company type
- Private
- Founded year
- 2017
- Operating status
- Closed
- Headcount range
- 1–10 employees
- Short description
- MediLedger brings together expertise in both Pharmaceutical Supply Chain and Blockchain technologies.
- Ownership category
- akta.pro rank
MediLedger industry classification
Industry- Product category
- Pharmaceutical Supply Chain Blockchain
- SIC
- Security & Commodity Brokers, Dealers, Exchanges & Services (6200)
- akta.pro primary industry
- Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features) (IMALAIAJ)
- akta.pro secondary industries
- Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI), Supply Chain & Inventory/Warehouse Receipt Tokenization (FSADAEAH), Pharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring (HLAFALAN)
Keywords
Where MediLedger is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
MediLedger business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
MediLedger product offering
Product offeringCore offering
MediLedger develops and operates a blockchain-based platform for pharmaceutical supply chain management. The offering focuses on drug traceability, anti-counterfeiting verification, and tamper-evident supply chain records to help pharmaceutical manufacturers meet DSCSA regulatory compliance requirements.
Differentiator
Problem solved
Functional benefit
Products and services
- MediLedger Pharmaceutical Blockchain Platform Blockchain-based platform that provides tamper-evident supply chain records, drug traceability, anti-counterfeiting verification, and DSCSA compliance tooling for pharmaceutical manufacturers and their supply chain partners.
Companies that use MediLedger
Customer profileSegments3 records
Ideal customer profiles3 records
MediLedger technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MediLedger partnerships and signals
Strategic signalScale indicators1 record
Recent moves1 record
Expansion highlights2 records
MediLedger competitors and assessment
Company assessmentDirect peers
- Chronicled: Chronicled operates the MediLedger Project, the blockchain pharmaceutical supply chain network directly comparable to MediLedger's offering. It is the closest functional peer in drug traceability and DSCSA compliance.
- TraceLink: TraceLink provides pharmaceutical supply chain serialization, traceability, and DSCSA compliance software to drug manufacturers and distributors, making it a direct competitor for compliance-driven pharma supply chain contracts.
- Optel Group: Optel Group provides traceability, serialization, and anti-counterfeiting solutions for pharmaceutical and other regulated supply chains, making it a direct competitor in drug traceability and supply chain integrity.
- RFXCEL (Antares Vision): RFXCEL, now part of Antares Vision, offers pharmaceutical serialization, track-and-trace, and supply chain integrity software, directly competing with MediLedger for pharma anti-counterfeiting and compliance contracts.
Broad incumbents
- IBM Blockchain (Healthcare & Pharma): IBM offers enterprise blockchain platforms with pharmaceutical supply chain use cases including drug traceability. It is a broad incumbent that competes for the same pharma blockchain deployments but with a much wider portfolio.
- SAP (Pharmaceutical Supply Chain / blockchain initiatives): SAP provides enterprise pharma supply chain solutions and has pursued blockchain-based serialization initiatives, competing for the same enterprise pharma customers as a broad incumbent with deep existing ERP relationships.
- Veeva Systems: Veeva Systems provides cloud software for the pharmaceutical and life sciences industry, including supply chain-adjacent and compliance solutions, making it a broad incumbent that touches the same pharma customer base.
Emerging players
- OriginTrail: OriginTrail builds blockchain-based supply chain interoperability solutions with pharma and healthcare use cases, overlapping with MediLedger on tamper-evident supply chain data and emerging as an alternative decentralization layer.
- Modum: Modum provides blockchain-based pharmaceutical supply chain monitoring and temperature compliance, addressing the same cold chain integrity and drug traceability problems as MediLedger in a focused, emerging-player capacity.
- FarmaTrust: FarmaTrust applies blockchain and AI to pharmaceutical supply chain integrity, anti-counterfeiting, and regulatory compliance, closely aligning with MediLedger's stated mission around drug authenticity verification.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
MediLedger social profiles
Digital presenceMediLedger financial estimates
Financial estimateRevenue estimate
Valuation estimate
MediLedger leadership team
Management profileNumber of profiles
Profiles2 records
MediLedger funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MediLedger M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MediLedger
What does MediLedger do?
MediLedger develops and operates a blockchain-based platform for pharmaceutical supply chain management. The offering focuses on drug traceability, anti-counterfeiting verification, and tamper-evident supply chain records to help pharmaceutical manufacturers meet DSCSA regulatory compliance requirements.
Is MediLedger a public or private company?
MediLedger is a private company. It is classified as unknown and is currently closed.
When was MediLedger founded?
MediLedger was founded in 2017. It employs 1 to 10 people.
Where is MediLedger based?
MediLedger is headquartered in San Francisco, United States, in the North America region.
Who are MediLedger's main competitors?
Direct peers on record are Chronicled, TraceLink, Optel Group and RFXCEL (Antares Vision). Broad incumbents are IBM Blockchain (Healthcare & Pharma), SAP (Pharmaceutical Supply Chain / blockchain initiatives) and Veeva Systems. Emerging players are OriginTrail, Modum and FarmaTrust.
Does MediLedger have an API?
No public API is recorded for MediLedger.
What industry is MediLedger in?
MediLedger's product category is Pharmaceutical Supply Chain Blockchain. Its primary akta.pro industry code is IMALAIAJ, Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features), with a secondary code of HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy). Its SIC code is 6200.